AU2015288635B2 — Visibility-ensuring material, and device for discharging visibility-ensuring material
Assigned to Menicon Co Ltd · Expires 2018-07-26 · 8y expired
What this patent protects
The purpose of the present invention is to provide a visibility-ensuring material which is capable of ensuring a surgical field for a fixed time period, which does not inhibit the transmission of light, and which is capable of ensuring visibility with which even delicate operatio…
USPTO Abstract
The purpose of the present invention is to provide a visibility-ensuring material which is capable of ensuring a surgical field for a fixed time period, which does not inhibit the transmission of light, and which is capable of ensuring visibility with which even delicate operations can be satisfactorily performed. This visibility-ensuring material includes a gel-like viscoelastic body, and has a storage elastic modulus during use of 40-700 Pa. Furthermore, this device for discharging the visibility-ensuring material includes at least at least one member selected from the group consisting of a syringe, a mesh filter, a needle, and an application nozzle.
Drugs covered by this patent
- Ycanth (CANTHARIDIN) · Verrica Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.